[HTML][HTML] Coverage rates for diphtheria, tetanus, poliomyelitis, and pertussis age-specific booster recommendations in France: 2018 update of the real-world cohort …

R Verdier, C Marchal, M Belhassen, M Le Pannerer… - Infectious Medicine, 2023 - Elsevier
Abstract The French National Immunization Program was updated in 2013 for vaccination
against diphtheria, tetanus, pertussis, and poliomyelitis. Our previous findings on the …

[HTML][HTML] Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an …

C Marchal, M Belhassen, N Guiso, F Jacoud… - Vaccine, 2021 - Elsevier
Background Maintaining a high vaccination coverage rate (VCR) throughout the lifetime and
complying with the National Immunization Program are essential to optimize the protection …

Impact of a dTcaP booster vaccine awareness campaign initiated by the French national health insurance for adults aged 25 years in 2021

A Hurtaud, C Coomans, B Vuillemin, A Benamar… - BMC Health Services …, 2023 - Springer
Background Vaccination schedules differ from country to country. In France, the diphtheria,
tetanus, pertussis, poliomyelitis (dTcaP) booster vaccine coverage for adults aged 25 has …

[HTML][HTML] Global routine vaccination coverage, 2018

M Peck - MMWR. Morbidity and mortality weekly report, 2019 - cdc.gov
Global Routine Vaccination Coverage, 2018 | MMWR Skip directly to site content Skip directly
to page options Skip directly to AZ link Centers for Disease Control and Prevention. CDC …

Evaluation of adult dTPaP vaccination coverage in France: experience in Lyon city, 2010–2011

D Baratin, C Del Signore, J Thierry, E Caulin… - BMC Public Health, 2012 - Springer
Background Compliance with official recommendations can be assessed by evaluating
vaccination coverage (VC) in populations. The main objective of our study was to assess VC …

Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study

J Paireau, S Guillot, FA El Belghiti… - The Lancet Infectious …, 2022 - thelancet.com
Summary Background In April–May, 2013, France modified its pertussis vaccination
schedule, which uses the acellular pertussis vaccine, from three primary doses at 2, 3, and 4 …

Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus …

R Dominicus, F Galtier, P Richard, M Baudin - Vaccine, 2014 - Elsevier
Introduction The immunogenicity and safety of one dose of Tdap-IPV (tetanus, diphtheria,
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …

[HTML][HTML] Pertussis Notification Rate and Tdpa Vaccine/Booster Coverage in Adults: An Opportunity for an Epidemiological Observatory in Primary Care

F Lapi, E Marconi, I Cricelli, A Rossi… - Infectious Disease …, 2024 - mdpi.com
Background: In recent years, Europe has experienced a significant increase in pertussis
cases. One reason behind this rise is the decline in diphtheria–tetanus–pertussis (dTap) …

[HTML][HTML] Advance system testing: can coverage of pertussis vaccination be estimated in European countries using electronic healthcare databases: an example

HD Emborg, J Kahlert, T Braeye, J Bauwens… - Vaccine, 2020 - Elsevier
Abstract Introduction The Accelerated Development of VAccine beNefit-risk Collaboration in
Europe (ADVANCE) is a public-private collaboration aiming to develop and test a system for …

Incidence of tetanus and diphtheria in relation to adult vaccination schedules

AM Slifka, B Park, L Gao… - Clinical Infectious Diseases, 2021 - academic.oup.com
Abstract Background The World Health Organization (WHO) does not recommend routine
adult booster vaccination for tetanus and diphtheria after completion of the childhood …